FDA Nod For BHVN's Drug, IBIO On Watch, SGMO Soars On Biogen Deal

Today's Daily Dose brings you news about FDA approval of Biohaven's migraine drug, iBio's Annual Meeting, Sangamo's deal with Biogen, and Zogenix's revised FDA decision date.

from RTT - Biotech https://ift.tt/2Tq9I0r
via IFTTT